AbbVie Inc. raised its revenue outlook for the 12 months on better-than-expected gross sales from newer autoimmune therapies, however warned its forecast doesn’t keep in mind any potential adjustments in commerce coverage. The drugmaker raised its 2025 adjusted earnings by 10 cents to a variety of $12.09 to $12.29 a...
- Login